头部和部血管肉瘤的治疗:系统性审查
Jessica E Houpe1, Edward W Seger1, Brett C Neill1
1Dr. Houpe is from the University of Kansas School of Medicine, Kansas City. Drs. Seger, Neill, and Hocker are from the Division of Dermatology, University of Kansas Medical Center, Kansas City. Drs. Kang and Alam are from the Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois. Dr. Alam also is from the Departments of Otolaryngology and Surgery. Dr. Tolkachjov is from Epiphany Dermatology, Lewisville, Texas; the Department of Dermatology, University of Texas at Southwestern, Dallas; Baylor University Medical Center, Dallas; and the Texas A&M College of Medicine, Dallas.
头部和部的原发性皮肤血管肉瘤 (cAS) 是罕见的,预后不佳. 这次系统性审查分析了头部和部cAS的治疗方法,发现手术和非手术选择的潜在疗效,但需要更多的数据.
科学领域:
- 在瘤学瘤学.
- 手术病理学手术病理学
- 皮肤病学 皮肤病学
背景情况:
- 头部和部的原发性皮肤血管肉瘤 (cAS) 是一种罕见的恶性瘤,在历史上预后不佳.
- 对于这种具有攻击性的软组织肉瘤,治疗选择和生存数据有限.
- 对头部和部cAS的最佳管理策略仍在调查中.
结论:
- 虽然手术和非手术方法都很有前途,但需要进一步的研究来确定头部和部cAS的最终治疗指南.
- 通过多学科合作,根据个体患者的因素量身定制治疗至关重要.
- 改善头部和部cAS的结果需要进一步研究有效的治疗策略.
相关概念视频
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistant Cancers